Altered Excitation-inhibition Balance in the Brain of Patients with Diabetic Neuropathy

Academic Radiology

Volumn 19, Issue 5, 2012, Pages 607-612

  Petrou, Myria ^a,c   Pop Busui, Rodica ^a   Foerster, Bradley R ^a,c,d   Edden, Richard A ^c,e   Callaghan, Brian C ^a   Harte, Steve E ^a   Harris, Richard E ^a   Clauw, Daniel J ^a,b   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^e KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Diabetes; MR spectroscopy; Neuropathy; Pain

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; NEUROTRANSMITTER;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ADULT; ALLODYNIA; ANTERIOR CINGULATE; ARTICLE; BRAIN; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC PATIENT; FEMALE; HISTOPATHOLOGY; HUMAN; INSULA; MALE; NERVE CELL INHIBITION; NERVE CELL STIMULATION; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PAIN; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SYMPTOM; THALAMUS;

BRAIN; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; PAIN;

EID: 84858991693     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2012.02.004     Document Type: Article

References (20)

1. Galer B.S., Gianas A., Jensen M.P. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000, 47:123-128.
2. Stewart W.F., Ricci J.A., Chee E., et al. Lost productive time and costs due to diabetes and diabetic neuropathic pain in the US workforce. J Occup Environ Med 2007, 49:672-679.
3. Ritzwoller D.P., Ellis J.L., Korner E.J., et al. Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting. Curr Med Res Opin 2009, 25:1319-1328.
4. Selvarajah D., Wilkinson I.D., Emery C.J., et al. Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus. Diabetologia 2008, 51:2088-2092.
5. Sorensen L., Siddall P.J., Trenell M.I., et al. Differences in metabolites in pain-processing brain regions in patients with diabetes and painful neuropathy. Diabetes Care 2008, 31:980-981.
6. Selvarajah D., Wilkinson I.D., Emery C.J., et al. Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care 2006, 29:2664-2669.
7. Cauda F., Sacco K., Duca S., et al. Altered resting state in diabetic neuropathic pain. PLoS One 2009, 4:e4542.
8. Harris R.E., Sundgren P.C., Craig A.D., et al. Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 2009, 60:3146-3152.
9. Prescot A., Becerra L., Pendse G., et al. Excitatory neurotransmitters in brain regions in interictal migraine patients. Molel Pain 2009, 5:34.
10. Mescher M., Merkle H., Kirsch J., et al. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998, 11:266-272.
11. Foerster B.R., Petrou M., Edden R.A., et al. Reduced insular gamma-aminobutyric acid in fibromyalgia. Arthritis Rheum 2012, 64:579-583.
12. Albers J.W., Herman W.H., Pop-Busui R., et al. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care 2010, 33:1090-1096.
13. Apfel S.C., Asbury A.K., Bril V., et al. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci 2001, 189(1-2):3-5.
14. Harris R.E., Sundgren P.C., Pang Y., et al. Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum 2008, 58:903-907.
15. Valdes M., Collado A., Bargallo N., et al. Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: a magnetic resonance spectroscopy study. Arthritis Rheum 2010, 62:1829-1836.
16. Fischer T.Z., Tan A.M., Waxman S.G. Thalamic neuron hyperexcitability and enlarged receptive fields in the STZ model of diabetic pain. Brain Res 2009, 1268:154-161.
17. Wang X.L., Zhang Q., Zhang Y.Z., et al. Downregulation of GABAB receptors in the spinal cord dorsal horn in diabetic neuropathy. Neurosci Lett 2011, 490:112-115.
18. Hertz L., Dringen R., Schousboe A., et al. Astrocytes: glutamate producers for neurons. J Neurosci Res 1999, 57:417-428.
19. Sachdev P.S., McBride R., Loo C., et al. Effects of different frequencies of transcranial magnetic stimulation (TMS) on the forced swim test model of depression in rats. Biol Psychiatry 2002, 51:474-479.
20. Rothman D.L., Behar K.L., Hyder F., et al. In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annu Rev Physiol 2003, 65:401-427.